EyePoint Pharmaceuticals
EYPT
EYPT
163 hedge funds and large institutions have $1.14B invested in EyePoint Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 58 increasing their positions, 36 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
3% less capital invested
Capital invested by funds: $1.18B → $1.14B (-$38.9M)
23% less call options, than puts
Call options by funds: $27.9M | Put options by funds: $36.1M
33.71% less ownership
Funds ownership: 144.11% → 110.39% (-34%)
Holders
163
Holding in Top 10
5
Calls
$27.9M
Puts
$36.1M
Top Buyers
| 1 | +$22.6M | |
| 2 | +$19.4M | |
| 3 | +$19M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$17.7M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$13.9M |
Top Sellers
| 1 | -$26.8M | |
| 2 | -$25.9M | |
| 3 | -$24.6M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$17.8M |
| 5 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
-$16.3M |